Clin2
NCT07419711Possibly a fitNot yet recruiting

Grape supplement to protect the heart during breast cancer chemotherapy

Chemotherapy-induced CardiotoxicityBreast Cancer

Part of Cancer, Skin clinical trials.

This study tests whether a natural supplement made from grape polyphenols can help protect the heart from damage caused by certain breast cancer chemotherapy drugs. It aims to see if taking this supplement alongside treatment can reduce the risk of heart problems.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
30 years to 75 years
Study type
Interventional

Who can take part

  • You are a woman between 30 and 75 years old.
  • You have breast cancer that has been confirmed by a biopsy.
  • Your planned chemotherapy will include a drug called an anthracycline or trastuzumab (Herceptin).
  • Your doctor has determined that you have a high risk (at least 20%) of heart damage from chemotherapy.
  • You are able to take oral study products (pills or capsules).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06023576Recruiting· Phase 2
Blood pressure control during breast cancer chemo

This study tests whether careful blood pressure management can help protect the heart during certain types of chemotherapy (anthracyclines) for breast cancer. Participants will use a smart blood pressure device and may also do an exercise test.

Basking Ridge, New Jersey
NCT06491680Recruiting· Phase 4
Heart safety during breast cancer chemo

This trial checks how well the heart handles anthracycline chemotherapy in breast cancer patients. It helps doctors find early signs of heart side effects so they can keep you safe during treatment.

Cairo, Cairo Governorate
NCT07254221Not yet recruiting· Phase 4
Can a statin protect your heart during breast cancer chemotherapy?

This trial tests whether taking the cholesterol-lowering drug rosuvastatin can protect your heart from damage caused by a common type of chemotherapy called anthracyclines. It may help reduce the risk of heart problems during breast cancer treatment.

Shiraz, Fars
NCT06427226Recruiting· Phase 2
Testing dapagliflozin to protect the heart during breast cancer chemo

This trial tests whether a daily pill called dapagliflozin can help protect the heart from damage caused by doxorubicin chemotherapy in people being treated for early-stage breast cancer. If you are starting doxorubicin and have a healthy heart, this might lower your risk of heart problems later.

Alexandria, Bab Sharqi
NCT07823660Recruiting
Heart-healthy exercise during breast cancer chemotherapy

This study tests a supervised exercise program for people with breast cancer who are about to start or are already in chemotherapy. The goal is to see if this type of rehabilitation helps keep your heart strong and improves your overall well-being during treatment.

Porto Alegre, Rio Grande do Sul
NCT05732051Recruiting· Phase 2
Nicotinamide riboside to protect the heart during breast cancer chemo

This trial tests whether nicotinamide riboside can help prevent heart problems caused by a common breast-cancer chemotherapy (anthracyclines). If you’re eligible, you’ll be followed to see how your heart is doing during treatment.

Lørenskog, Akershus

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.